Prospectus Supplement

 

Filed Pursuant to Rule 424(b)(3)
Registration No. 333-171998

Prospectus Supplement to Prospectus dated April 23, 2012

InVivo Therapeutics Holdings Corp.

26,047,200 Shares of Common Stock

This prospectus supplement updates the prospectus dated April 23, 2012 relating to the offer for sale of up to an aggregate of 26,047,200 shares of common stock of InVivo Therapeutics Holdings Corp. by the selling securityholder identified in the prospectus and this prospectus supplement, and any of their pledgees, donees, transferees or other successors in interest.

We are providing this prospectus supplement to update the table in the prospectus under the caption “Selling Securityholders” to reflect a transfer of shares and a warrant to purchase shares of common stock, from Richard Ernest to the Richard C. Ernest Revocable Trust. The amounts set forth below are based upon information provided to us by the selling securityholder (or his representatives), or on our records, and are accurate to the best of our knowledge. Unless we indicate otherwise, the information in this prospectus supplement is as of April 27, 2012.

 

     Securities
Beneficially Owned

Prior to the Offering
     Securities Offered Hereby      Securities Beneficially
Owned After this
Offering
 

Name

   Common
Stock (1)
     Warrants      Common
Stock
     Common
Stock
Underlying

Warrants
     Common
Stock
     Warrants  

Richard Ernest

     N/A         N/A         N/A         N/A         N/A         N/A   

Richard C. Ernest, TR UA 05/15/2009, Richard C. Ernest Revocable Trust

     25,000         25,000         25,000         25,000         —           —     

 

(1) Does not include shares of common stock underlying the warrants.

This prospectus supplement is not complete without the prospectus dated April 23, 2012, and we have not authorized anyone to deliver or use this prospectus supplement without the prospectus.

The date of this prospectus supplement is April 30, 2012.